Hunan Hansen Pharmaceutical Co., Ltd.

SZSE:002412.SZ

6.55 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 1,004.469955.531916.062891.835741.237887.491921.95829.938798.467781.128737.425584.932489.461400.786343.415283.211235.689166.939126.747
Cost of Revenue 242.531262.776255.9245.857220.124232.402236.736224.991230.315225.917212.041151.769122.62296.15280.65967.28857.77144.33736.958
Gross Profit 761.939692.754660.162645.978521.113655.089685.214604.947568.152555.211525.384433.164366.839304.634262.756215.923177.918122.60189.789
Gross Profit Ratio 0.7590.7250.7210.7240.7030.7380.7430.7290.7120.7110.7120.7410.7490.760.7650.7620.7550.7340.708
Reseach & Development Expenses 39.32244.47947.939.4531.22733.45136.44350.78347.8552.41427.22520.0427.3684.49100000
General & Administrative Expenses 22.43224.218.24414.497-24.591-30.828-32.308-55.39-51.412-49.90214.93823.08713.0018.59133.68119.98319.90613.10713.653
Selling & Marketing Expenses 284.617292.96396.035401.257334.014362.652428.846382.585380.895354.91308.986244.89244.808217.39164.813129.30399.63759.65747.732
SG&A 307.049451.773414.279415.753309.423331.824396.538327.195329.483305.008323.923267.977257.809225.981198.494149.287119.54472.76561.384
Other Expenses 162.384-43.17756.99560.86683.22294.013-0.345-3.4554.5533.1541.6361.984-13.788-13.2166.2674.1784.72318.2490.373
Operating Expenses 508.755457.817519.173516.069423.872459.289534.712473.835472.646447.297393.909315.685287.892249.765204.029153.66123.08475.09363.063
Operating Income 253.184234.937188.791150.272117.87184.955159.461120.03284.404105.965129.946129.08193.87868.59366.82258.53850.44742.13218.689
Operating Income Ratio 0.2520.2460.2060.1680.1590.2080.1730.1450.1060.1360.1760.2210.1920.1710.1950.2070.2140.2520.147
Total Other Income Expenses Net -0.427-8.92-6.938-0.371-1.5591.148-0.345-9.388-6.64711.42.451.832.4160.95215.247-2.1-3.43612.9890.373
Income Before Tax 252.757226.017181.853149.901116.312186.103159.116116.57688.617110.804132.396130.91196.29469.54573.08959.57751.09160.38119.062
Income Before Tax Ratio 0.2520.2370.1990.1680.1570.210.1730.140.1110.1420.180.2240.1970.1740.2130.210.2170.3620.15
Income Tax Expense 32.51221.00214.23715.05211.48526.40718.35218.43514.45517.06620.09819.79514.83510.71811.06810.3268.59620.4226.507
Net Income 220.244205.015167.616134.849106.146159.696140.76498.14271.49292.656111.8110.83381.45958.82762.02149.2542.49537.87411.248
Net Income Ratio 0.2190.2150.1830.1510.1430.180.1530.1180.090.1190.1520.1890.1660.1470.1810.1740.180.2270.089
EPS 0.440.410.330.270.210.320.280.20.150.180.220.220.160.120.140.130.110.10.029
EPS Diluted 0.440.410.330.270.210.320.280.20.150.180.220.220.160.120.140.130.110.10.029
EBITDA 296.082280.663147.739207.612174.954243.685202.29181.465133.81151.702170.679141.827105.51681.36382.35170.9362.43768.11928.478
EBITDA Ratio 0.2950.2940.1610.2330.2360.2750.2190.2190.1680.1940.2310.2420.2160.2030.240.250.2650.4080.225